We are live on ! Find out more
CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

78 hedge funds and large institutions have $168M invested in Cascadian Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 5

165% more capital invested

Capital invested by funds: $63.3M → $168M (+$105M)

150% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 10

37% more funds holding

Funds holding: 57 → 78 (+21)

Holders
78
Holders Change
+21
Holders Change %
+36.84%
% of All Funds
1.94%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
30
Increased
25
Reduced
10
Closed
5
Calls
$741K
Puts
–
Net Calls
+$741K
Net Calls Change
+$202K

Top Buyers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
+$30.6M
2
BG
Baupost Group
Massachusetts
+$19.1M
3
RG
Redmile Group
California
+$17.1M
4
EC
EcoR1 Capital
California
+$12.6M
5
A
Abingworth
United Kingdom
+$3.89M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$2.29M
2
FO
FT Options
Illinois
-$145K
3
First Eagle Investment Management
First Eagle Investment Management
New York
-$108K
4
VKH
Virtu KCG Holdings
New York
-$97.7K
5
EWM
Edge Wealth Management
New York
-$85K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$572K +$507K +120,565 +688%
Morgan Stanley
27
Morgan Stanley
New York
$430K +$431K +102,562 +8,366%
Handelsbanken Fonder
28
Handelsbanken Fonder
Sweden
$348K – – –
TC
29
TFS Capital
Pennsylvania
$314K +$319K +75,784 New
Northern Trust
30
Northern Trust
Illinois
$307K +$194K +46,142 +164%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$276K +$226K +53,696 +414%
SCM
32
Segantii Capital Management
Hong Kong
$243K +$247K +58,647 New
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$238K +$242K +57,525 New
PCM
34
Perkins Capital Management
Minnesota
$199K +$12.1K +2,887 +6%
SKK
35
Shepherd Kaplan Krochuk
Massachusetts
$160K +$50.6K +12,048 +45%
Squarepoint
36
Squarepoint
New York
$156K +$158K +37,650 New
Bank of America
37
Bank of America
North Carolina
$155K +$151K +35,975 +2,316%
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$153K +$155K +36,885 New
Citadel Advisors
39
Citadel Advisors
Florida
$142K +$143K +34,115 New
State Street
40
State Street
Massachusetts
$140K +$95.4K +22,700 +203%
ARTA
41
A.R.T. Advisors
New York
$140K +$143K +34,019 New
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$133K +$135K +32,229 New
BCM
43
BlueCrest Capital Management
Jersey
$122K +$124K +29,400 New
Barclays
44
Barclays
United Kingdom
$120K +$114K +27,172 +1,364%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$115K – – –
LTFS
46
Ladenburg Thalmann Financial Services
Florida
$92K +$36.8K +8,747 +65%
Bank of New York Mellon
47
Bank of New York Mellon
New York
$85K -$32.7K -7,788 -27%
TI
48
Telemetry Investments
New York
$75K -$13.9K -3,310 -15%
Renaissance Technologies
49
Renaissance Technologies
New York
$74K +$75.6K +17,988 New
AIM
50
Alambic Investment Management
California
$61K +$62K +14,750 New
1
2
3 4

CASC Hedge Fund Activity: Q1 2017 in Review

78 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Cascadian Therapeutics, Inc. (CASC) for Q1 2017, worth a combined $168M — up 165% from $63.3M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new CASC positions and 5 closed out — a net gain of 25 holders — while 25 added to existing stakes and 10 trimmed.

The largest buyer was NEA Management Company, adding an estimated $30.6M. The largest seller was Perceptive Advisors, cutting an estimated $2.29M.

  • 78 institutional investors held Cascadian Therapeutics, Inc. (CASC) as of Q1 2017, up from 57 in Q4 2016.
  • Funds reported $168M of Cascadian Therapeutics, Inc. stock for Q1 2017, up 165% quarter-over-quarter.
  • 30 funds opened new Cascadian Therapeutics, Inc. positions in Q1 2017 and 5 closed out, a net change of +25 holders.
  • The largest Cascadian Therapeutics, Inc. buyer in Q1 2017 was NEA Management Company, an estimated $30.6M added.
  • The largest Cascadian Therapeutics, Inc. seller in Q1 2017 was Perceptive Advisors, an estimated $2.29M sold.

Based on aggregated 13F filings for Q1 2017.